Section one: Contracting authority/entity
one.1) Name and addresses
NHS Blood & Transplant
North Bristol Park
Filton, Bristol
Telephone
+44 1179217253
Country
United Kingdom
NUTS code
UK - UNITED KINGDOM
Internet address(es)
Main address
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Supply of testing for SARS-CoV-2 antibody and PCR testing
Reference number
NHSBT1386
two.1.2) Main CPV code
- 85111810 - Blood analysis services
two.1.3) Type of contract
Services
two.2) Description
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement at the time of conclusion of the contract:
NHS Blood and Transplant (NHSBT) are leading the Convalescent Plasma programme to explore the efficacy of donated plasma in the treatment of severe COVID-19 disease. Plasma will be donated by individuals who have recovered from COVID-19 disease and those plasma units with a sufficiently high level of antibody will be used as a treatment. Public Health England (PHE) will be carrying out Testing on the Materials on behalf of NHSBT. This will involve:
- A SARS-CoV-2 IgG antibody Testing service to NHSBT to enable the identification of convalescent plasma donations with sufficient level of antibody.
- A SARS-CoV-2 PCR and RNA Testing service to NHSBT to support the Convalescent Plasma programme of work at NHSBT.
two.2.7) Duration of the contract, framework agreement, dynamic purchasing system or concession
End date
31 March 2021
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.2) Administrative information
four.2.1) Contract award notice concerning this contract
Notice number: 2020/S 118-288015
Section five. Award of contract/concession
Contract No
NHSBT1386
Title
Supply of testing for SARS-CoV-2 antibody testing
five.2) Award of contract/concession
five.2.1) Date of conclusion of the contract/concession award decision:
16 March 2021
five.2.2) Information about tenders
The contract/concession has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor/concessionaire
Public Health England
Sailsbury
Country
United Kingdom
NUTS code
- UK - UNITED KINGDOM
The contractor/concessionaire is an SME
No
five.2.4) Information on value of the contract/lot/concession (at the time of conclusion of the contract;excluding VAT)
Total value of the procurement: £275,000
Section six. Complementary information
six.4) Procedures for review
six.4.1) Review body
NHS Blood and Transplant
Bristol
Country
United Kingdom
Section seven: Modifications to the contract/concession
seven.1) Description of the procurement after the modifications
seven.1.1) Main CPV code
- 85111810 - Blood analysis services
seven.1.3) Place of performance
NUTS code
- UK - UNITED KINGDOM
seven.1.4) Description of the procurement:
NHS Blood and Transplant (NHSBT) are leading the Convalescent Plasma programme to explore the efficacy of donated plasma in the treatment of severe COVID-19 disease. Plasma will be donated by individuals who have recovered from COVID-19 disease and those plasma units with a sufficiently high level of antibody will be used as a treatment. Public Health England (PHE) will be carrying out Testing on the Materials on behalf of NHSBT. This will involve a SARS-CoV-2 IgG antibody Testing service (using a CE-marked assay) to NHSBT to enable the identification of convalescent plasma donations with sufficient level of antibody.
seven.1.5) Duration of the contract, framework agreement, dynamic purchasing system or concession
End date
31 March 2022
seven.1.6) Information on value of the contract/lot/concession (excluding VAT)
Total value of the contract/lot/concession:
£105,000
seven.1.7) Name and address of the contractor/concessionaire
Public Health England
Sailsbury
Country
United Kingdom
NUTS code
- UK - UNITED KINGDOM
The contractor/concessionaire is an SME
No
seven.2) Information about modifications
seven.2.1) Description of the modifications
Nature and extent of the modifications (with indication of possible earlier changes to the contract):
Duration extended from 31st March 2021 to 31st March 2022 to allow for testing of c. 7000 research samples from the RECOVERY clinical trial.
seven.2.2) Reasons for modification
Need for additional works, services or supplies by the original contractor/concessionaire.
Description of the economic or technical reasons and the inconvenience or duplication of cost preventing a change of contractor:
The Rare and Imported Pathogens Laboratory (RIPL) based at PHE Porton (Sailsbury), providing the SARS-CoV-2 IgG antibody testing service, have experience in handling samples from NHSBT meeting all criteria specified in section 4.1 of the Project Schedule (dated 3rd March 2021). It is the only facility of its type within the UK that has the expertise to perform a quantitative test for SARS-CoV-2 IgG with a linear correlation with neutralising antibody over a very wide range of titres at the scale and speed required to meet the time pressures associated with the convalescent plasma programme.
seven.2.3) Increase in price
Updated total contract value before the modifications (taking into account possible earlier contract modifications, price adaptions and average inflation)
Value excluding VAT: £275,000
Total contract value after the modifications
Value excluding VAT: £380,000